FDA label 280f3177-defc-4e55-804a-ebea39262396

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
3b2d2296-eefb-4b06-ad4b-4e94966538a2
SPL ID
280f3177-defc-4e55-804a-ebea39262396
Version
7
Effective date
2016-04-07
Source export date
2026-09-28
Source partition
5
Source file
https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/9839785a692b692224cd5f90f9e3a9514c9923a6f521ab83eed3bedc7c0e1d05/drug-label-0005-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:30:30

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Accidental Exposure in Children: the potential exists for a small child or a pet to suffer adverse effects from chewing or ingesting a new or used Xyphex Biofrequency Chips. It is important for patients to store and dispose of Xyphex Biofrequency Chip out of the reach of children and pets. For external use only. Although the Xyphex Biofrequency Chip contains low frequency waves, it has not been studied with a cardiac pacemaker or defibrillator. Consultation with the attending cardiologist is recommended for patients with implanted electrical devices. The Xyphex Biofrequency Chip should be removed prior to any imaging procedures (e.g. CT scan, MRI, X-ray etc.). The Xyphex Biofrequency Chip should not be used if there are mental or physical conditions that may preclude compliance with physician instructions. PRECAUTIONS: When traveling by air, do not wear the Xyphex Biofrequency Chip when passing through passenger screening devices or the biofrequency chip could be damaged. Application to broken or inflamed skin, although not tested, may result in higher blood concentrations from increased absorption. Xyphex Biofrequency Chip is only recommended for use on intact skin. The contact of Xyphex Biofrequency Chip with eyes, although not studied, should be avoided based on the findings of severe eye irritations with the use of similar products in animals. If eye contact occurs, immediately wash out the eye with water or saline. PREGNANCY: The safety of Xyphex Biofrequency Chip has not been established during pregnancy. ADVERSE REACTIONS: The most common adverse reactions are application site reactions, including dermatitis, itching or scaling. These tend to be dose-limiting and diminish with time. OVER DOSAGE: There have been no reports of over dosage with Xyphex Biofrequency Chip. Signs of over dosage could include vomiting, drowsiness, coma, respiratory depression, and seizures. In the case of an over dosage, discontinue the product immediately, treat the patient symptomatically, and institute supportive measures.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.